Patents by Inventor Ira L. Goldknopf

Ira L. Goldknopf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100167937
    Abstract: The present invention relates to identification and uses of biomarkers for neurodegenerative disease, including Alzheimer's disease, and the related diseases. More specifically, the present invention relates to the identification of protein biomarkers useful for the screening, diagnosis, and differentiation of Alzheimer's disease from Parkinson's disease, other neurodegenerative diseases, and normal controls, and in the monitoring of Alzheimer's disease severity and disease mechanisms in patients.
    Type: Application
    Filed: July 8, 2008
    Publication date: July 1, 2010
    Applicant: Power3 Medical Products, Inc.
    Inventors: Ira L. Goldknopf, Jennifer K. Bryson, Essam A. Sheta, Jaffer K. Khalil, Silvia C. Quintero
  • Publication number: 20100129846
    Abstract: The present invention discloses twenty two 22 protein biomarkers of breast cancer. More specifically, the present invention discloses the identities, specificities, and uses of up to twenty two (22) protein biomarkers in blood serum for distinguishing between patients with earlier and later stages of breast cancer, patients with benign breast diseases or abnormalities, and normal individuals lacking breast abnormalities. More specifically, the present invention relates to specificities of isoforms of up to 22 protein biomarkers in blood serum for distinguishing between patients with earlier and later stages of breast cancer, patients with benign breast diseases or abnormalities, and normal individuals lacking breast abnormalities.
    Type: Application
    Filed: November 17, 2008
    Publication date: May 27, 2010
    Applicant: Power3 Medical Products, Inc.
    Inventor: Ira L. Goldknopf
  • Publication number: 20100004871
    Abstract: The present invention discloses twenty two 22 protein biomarkers of breast cancer. More specifically, the present invention discloses the identities, specificities, and uses of up to twenty two (22) protein biomarkers in blood serum for distinguishing between patients with earlier and later stages of breast cancer, patients with benign breast diseases or abnormalities, and normal individuals lacking breast abnormalities.
    Type: Application
    Filed: November 17, 2008
    Publication date: January 7, 2010
    Applicant: Power3 Medical Products, Inc.
    Inventor: Ira L. Goldknopf
  • Publication number: 20090275046
    Abstract: The present invention relates to a Complement Factor H protein as a biomarker for neurodegenerative disease, including Parkinson's disease, and the related diseases. More specifically, the present invention relates to the identification of a Complement Factor H protein, useful for the screening, diagnosis, and differentiation between neurodegenerative diseases.
    Type: Application
    Filed: August 29, 2007
    Publication date: November 5, 2009
    Inventors: Ira L. Goldknopf, Essam A. Sheta, Jennifer K. Bryson
  • Publication number: 20090061457
    Abstract: The present invention relates to an Apolipoprotein E3 protein as a biomarker for neurodegenerative disease, including Parkinson's disease, and the related diseases. More specifically, the present invention relates to the identification of an Apolipoprotein E3 protein, useful for the screening, diagnosis, and differentiation of Parkinson's disease from Alzheimer's disease, other neurodegenerative diseases, and normal controls.
    Type: Application
    Filed: September 5, 2007
    Publication date: March 5, 2009
    Inventors: Ira L. Goldknopf, Essam A. Sheta, Jennifer K. Bryson
  • Publication number: 20030211624
    Abstract: A method of diagnosing a cancerous condition in a female includes analyzing ductal secretions from each breast of a female subject in which differences in the protein profiles of the two samples are indicative of a cancerous condition. Protein samples are preferable analyzed by two dimensional gel electrophoresis or by microarrays. Identification of cancer markers and monitoring progression and treatment of cancers, and especially breast cancer are also dislcosed.
    Type: Application
    Filed: November 20, 2002
    Publication date: November 13, 2003
    Applicant: Board of Regents, The University of Texas System
    Inventors: Ira L. Goldknopf, Helen R. Park, Herbert A. Fritsche, Henry M. Kuerer